Evidence map›Paper›PMID 25423491›Full record

ArticlePloS one2014

Characterization of N-acyl phosphatidylethanolamine-specific phospholipase-D isoforms in the nematode Caenorhabditis elegans.

Neale Harrison, Museer A Lone, Tiffany K Kaul, Pedro Reis Rodrigues, Ifedayo Victor Ogungbe, Matthew S Gill

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Lactate promotes longevity through redox-driven lipid remodeling inbioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The Endocannabinoid System in Caenorhabditis elegans.Reviews of physiology, biochemistry and pharmacology · 2023
    Review
  9. Pan-phylumFrontiers in endocrinology · 2022
    Article
  10. Review
  11. Article
  12. Review
  13. Comparative studies of endocannabinoid modulation of pain.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Neale HarrisonDepartment of Metabolism & Aging, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America.
Museer A LoneDepartment of Metabolism & Aging, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America.
Tiffany K KaulDepartment of Metabolism & Aging, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America.
Pedro Reis RodriguesDepartment of Metabolism & Aging, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America.
Ifedayo Victor OgungbeDepartment of Metabolism & Aging, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America.
Matthew S GillDepartment of Metabolism & Aging, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America.
Scripps Research Institute · US

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
Endocannabinoid signaling and agingR01AG036992 · NIA · SCRIPPS FLORIDA · PI GILL, MATTHEW SIMON · 2010 to 2014
$1.9M
NIA NIH HHS AG036992NIA NIH HHS R01 AG036992NIH HHS P40 OD010440
6 · The paper itself

Abstract

N-acylethanolamines are an important class of lipid signaling molecules found in many species, including the nematode Caenorhabditis elegans (C. elegans) where they are involved in development and adult lifespan. In mammals, the relative activity of the biosynthetic enzyme N-acyl phosphatidylethanolamine-specific phospholipase-D and the hydrolytic enzyme fatty acid amide hydrolase determine N-acylethanolamine levels. C. elegans has two N-acyl phosphatidylethanolamine-specific phospholipase-D orthologs, nape-1 and nape-2, that are likely to have arisen from a gene duplication event. Here, we find that recombinant C. elegans NAPE-1 and NAPE-2 are capable of generating N-acylethanolamines in vitro, confirming their functional conservation. In vivo, they exhibit overlapping expression in the pharynx and the nervous system, but are also expressed discretely in these and other tissues, suggesting divergent roles. Indeed, nape-1 over-expression results in delayed growth and shortened lifespan only at 25°C, while nape-2 over-expression results in significant larval arrest and increased adult lifespan at 15°C. Interestingly, deletion of the N-acylethanolamine degradation enzyme faah-1 exacerbates nape-1 over-expression phenotypes, but suppresses the larval arrest phenotype of nape-2 over-expression, suggesting that faah-1 is coupled to nape-2, but not nape-1, in a negative feedback loop. We also find that over-expression of either nape-1 or nape-2 significantly enhances recovery from the dauer larval stage in the insulin signaling mutant daf-2(e1368), but only nape-1 over-expression reduces daf-2 adult lifespan, consistent with increased levels of the N-acylethanolamine eicosapentaenoyl ethanolamine. These results provide evidence that N-acylethanolamine biosynthetic enzymes in C. elegans have conserved function and suggest a temperature-dependent, functional divergence between the two isoforms.

Indexed as

Amino Acid SequenceAnimalsCaenorhabditis elegansEthanolaminesIsoenzymesMolecular Sequence DataPhospholipase DEthanolaminesIsoenzymesN-acylethanolaminesPhospholipase D

Identifiers

PMID25423491
PMCPMC4244089
OpenAlexW2081283341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.